GeoMx® Canine Cancer Atlas

Helping Your Research

Use the GeoMx Canine Cancer Atlas to study the canine immune response to cancer as well as to immuno-oncology treatments. Profile 1,962 RNA targets with spatial resolution and spike in up to 400 custom RNA targets to add in probes for non-coding RNA, synthetic DNA, or exogenous genes. 

Built with input from experts in canine comparative oncology, the Canine Cancer Atlas contains overlapping content with the nCounter® Canine IO Panel, allowing you to seamlessly transition your comparative oncology studies from bulk gene expression analysis to spatial transcriptomics.

Circular "Wheel" graphic with a dog illustration

How It Works

The Canine Cancer Atlas targets transcripts specific to the onset and progression of cancer in canines as well as the canine immune response to cancers.


Superior Sensitivity

Leverage the power of digital spatial profiling with NGS readout to profile low, medium, and high expressing genes and minimize sequencing spend


Scalable Throughput

Automated staining with the BOND RX Fully Automated Research Stainer from Leica Biosystems enables large cohort analysis


Annotated Content

Coverage includes 1,962 genes annotated across 110 pathways as well as 48 controls


Tumor-Specific Content

Targets include those involved in common canine cancer such as melanoma, osteosarcoma, lymphoma, urothelial carcinoma, and glioblastoma


Integrated Analysis

Reagent Planning Tool

Find the Perfect GeoMx DSP Reagent

GeoMx DSP Reagent Planning Tool

Related Resources

See All Resources
GeoMx® Canine Cancer Atlas – Product Bulletin
Event NanoString 5th Annual Spatial Genomics Summit
Whitepaper GeoMx RBS Selection and Optimization – White Paper
Gene/Probe List Canine Cancer Atlas Gene list
Manual/Instructions GeoMx® DSP: Data Analysis for NGS Readout

Selected Panel References

View All Publications

Characterization and Potential Applications of Dog Natural Killer Cells in Cancer Immunotherapy

Natural killer (NK) cells of the innate immune system are a key focus of research within the field of immuno-oncology based on their ability to recognize and eliminate malignant cells without prior sensitization or priming. However, barriers have arisen in the effective translation of NK cells to the clinic, in part because of critical species differences between mice and humans.

Top 10 Challenges in Cancer Immunotherapy

Cancer immunotherapy is a validated and critically important approach for treating patients with cancer. Given the vast research and clinical investigation efforts dedicated to advancing both endogenous and synthetic immunotherapy approaches, there is a need to focus on crucial questions and define roadblocks to the basic understanding and clinical progress.

Whole genome sequencing of canids reveals genomic regions under selection and variants influencing morphology

Domestic dog breeds are characterized by an unrivaled diversity of morphologic traits and breed-associated behaviors resulting from human selective pressures. To identify the genetic underpinnings of such traits, we analyze 722 canine whole genome sequences (WGS), documenting over 91 million single nucleotide and small indels, creating a large catalog of genomic variation for a companion animal species.

Request a Quote

Contact our helpful experts and we’ll be in touch soon.